These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3485461)

  • 1. In vivo induction of terminal differentiation of malignant myelopoietic progenitor cells by CSF-inducing biological response modifiers.
    Schlick E; Ruscetti FW
    Blood; 1986 Apr; 67(4):980-7. PubMed ID: 3485461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers.
    Schlick E; Ruffmann R; Hartung K; Chirigos MA
    J Immunopharmacol; 1985; 7(1):141-66. PubMed ID: 3874241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of poly(I,C)-LC on growth and differentiation of normal and malignant myelopoietic progenitor cells.
    Schlick E; Bettens F; Ruffmann R; Chirigos MA; Hewetson P
    J Biol Response Mod; 1985 Dec; 4(6):628-33. PubMed ID: 3878862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response by biological response modifiers.
    Chirigos MA; Schlick E; Budzynski W
    Cancer Detect Prev Suppl; 1987; 1():385-97. PubMed ID: 3500779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers.
    Schlick E; Hartung K; Chirigos MA
    Cancer Immunol Immunother; 1984; 18(3):226-32. PubMed ID: 6334554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinduction of differentiation in WEHI-3B leukemia cells.
    Metcalf D; Nicola NA
    Int J Cancer; 1982 Dec; 30(6):773-80. PubMed ID: 6984432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo control of differentiation of myeloid leukemic cells by cyclosporine A and recombinant interleukin-1 alpha.
    Lotem J; Sachs L
    Blood; 1988 Nov; 72(5):1595-601. PubMed ID: 2460157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
    Lotem J; Sachs L
    Blood; 1988 Feb; 71(2):375-82. PubMed ID: 2447982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.
    Metcalf D; Hilton DJ; Nicola NA
    Leukemia; 1988 Apr; 2(4):216-21. PubMed ID: 2452326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators.
    Moore MA
    J Cell Physiol Suppl; 1982; 1():53-64. PubMed ID: 6802860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
    Bettens F; Schlick E; Farrar W; Ruscetti F
    J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of differentiation-inducing factor and other cytokines on induction of differentiation of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M; Maurer HR; Okabe T; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):115-21. PubMed ID: 2470711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media--separation from colony-stimulating factors.
    Nicola NA; Metcalf D
    J Cell Physiol; 1981 Nov; 109(2):253-64. PubMed ID: 6975280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.
    Gabrilove JL; Welte K; Lu L; Castro-Malaspina H; Moore MA
    Blood; 1985 Aug; 66(2):407-15. PubMed ID: 2990610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
    Brach MA; Mertelsmann RH; Herrmann F
    Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells.
    Metcalf D
    Leukemia; 1989 May; 3(5):349-55. PubMed ID: 2469911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.